Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease Post author: Post published:November 15, 2023 Post category:uncategorized Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson’s disease (PD). You Might Also Like ChatGPT shown to save time in responding to patient inquiries August 22, 2024 SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel March 17, 2025 Study sheds new light on the mechanisms underlying head and neck cancer metastasis March 27, 2025
SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel March 17, 2025